HHS Secretary Robert F. Kennedy Jr. addressed criticism from Make America Healthy Again activists after extending liability protections for drugmakers developing treatments for the Andes hantavirus strain. The protections for the antiviral drug favipiravir were announced on May 26, 2026, and will last until July 18.
Our neutral summary
HHS Secretary Robert F. Kennedy Jr. addressed criticism from Make America Healthy Again activists after extending liability protections for drugmakers developing treatments for the Andes hantavirus strain. The protections for the antiviral drug favipiravir were announced on May 26, 2026, and will last until July 18.
The reporting belongs to The Hill; we don't reproduce it.
No note attached
on this article.
Kennedy faces anti-vax anger over hantavirus treatment legal protections
HHS Secretary Kennedy Responds to Criticism Over Hantavirus Treatment Protections